Hal Gunn News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Hal Gunn. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Hal Gunn Today - Breaking & Trending Today

Qu Biologics and TransBIOTech Awarded $450K Applied Research and Development Grant Funding

Published: March 11, 2024

BURNABY, British Columbia, March 11, 2024 (GLOBE NEWSWIRE) -- Qu Biologics Inc., a clinical stage biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a novel platform of immunotherapies designed to restore innate immune function, is pleased to announce, in partnership with TransBIOTech (Quebec), being awarded an Applied Research and Development (ARD) grant via the College and Community Innovation (CCI) program administered through the Natural Sciences and Engineering Coun

Source: yahoo.com

Hikes in fertilizer costs lead some farmers to use soil amendments

Published: April 18, 2023

While some detest soil amendments, other Georgia farmers see the benefits, especially when considering rising fertilizer costs.

Source: augustachronicle.com

Related Topics:

Warren County United States Jefferson County Taylor Harbinson Hal Gunn Katie Goodale Joe Mckenzie Augusta Chronicle United States Materials Company Georgia Department Of Agriculture Department Of Agriculture Georgia Department Recovered Materials Company Georgia Soil Amendment Act

Dr. Matt Cahill Appointed Chief Operating Officer of Qu Biologics

Published: January 24, 2023

Dr. Matt Cahill Appointed Chief Operating Officer of Qu Biologics - read this article along with other careers information, tips and advice on BioSpace

Source: biospace.com

Related Topics:

United Kingdom Hal Gunn Simon Sutcliffe Matt Cahill Ted Steiner University Of Toronto University Of Cambridge Bc Cancer Agency Division Of Infectious Diseases Qu Biologics Inc British Columbia Biologics Inc Site Specific Immunomodulators Chief Operating Deep Genomics Chief Medical Officer Infectious Disease Infectious Diseases R Matt Cahill Appointed Chief Operating Officer Of Qu Biologics

Qu Biologics to Receive $6.7 Million in IRAP Funding to Support Innovative New Treatment to Restore Innate Immune Function in the Elderly

Published: October 27, 2022

Qu Biologics to Receive $6.7 Million in IRAP Funding to Support Innovative New Treatment to Restore Innate Immune Function in the Elderly. Vancouver, BC, October 27, 2022--Qu Biologics Inc., a clinical stage biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a novel platform of immunotherapies designed to restore innate immune function, announced that it is receiving advisory services and research and development funding of up to $6,659,050 from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP).

Source: bctechnology.com

Related Topics:

British Columbia Hal Gunn Ted Steiner Qu Biologics Inc Site Specific Immunomodulators National Research Council Canada Industrial Research Assistance Program Infectious Diseases Shirin Kalyan Scientific Innovation